WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Events
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Affiliated Programs

10.21.26

Intellectual Property (IP) for Antibody and Related Therapeutics: Strategies, Best Practices and Case Studies
Antibody and related biologic therapeutics present unique intellectual property (IP) challenges throughout discovery, development, and commercialization. This online workshop will bring together IP attorneys and industry experts from Haynes Boone, Wilson Sonsini, Morgan Lewis, Morrison Foerster, and Amgen to discuss practical strategies, emerging legal issues, and real-world case studies. Attendees will gain insights into protecting innovation, managing IP risks, and navigating an evolving legal landscape shaped by advances in biologics and AI.
Affiliated Programs

10.20.26

East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs

10.16.26

Discovery and Development of Orally Bioavailable Peptides from Concept to Clinic: Structural Design, Formulation Development, Translational Science, and IP Issues
Wilson Sonsini is proud to sponsor the Pharmaceutical & BioScience Society (PBSS).
Affiliated Programs

9.15.26

West Coast NextGen VC Forum
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs

8.05.26

7th In-House Impact: Biopharma Summit
Wilson Sonsini is pleased to sponsor the 7th In-House Impact: Biopharma Summit, a premier gathering designed exclusively for general counsels, chief legal officers, and senior in-house legal leaders across the biopharma industry.
Affiliated Programs

7.22.26

WIB-San Francisco Bay Area & PBSS: Symposium on the Advances in the Development of Therapeutics and Diagnostics for Women’s Health
PBSS is teaming up with Women in Bio (WIB) to host a virtual symposium focused on therapies and diagnostics for women’s health. You’ll hear from other speakers in industry, academia, and non-profit research organizations on their experience raising funding, setting new healthcare standards, and advocating for women’s health. Sara Kenkare-Mitra, formerly at Genentech and Alector, will give a plenary talk followed by panelists from the Gates Foundation, the Buck Institute, and industry experts. At the end of the symposium, there will be a panel for deeper conversations on the successes and current challenges in this space. This is a free industry event; register today.
Affiliated Programs

7.15.26

Compensation Confidential 2026: Preparing for Investors and Scaling Your Team
Wilson Sonsini is proud to support LaunchBio’s Beyond the Pitch webinar series. We invite you to tune in for Compensation Confidential 2026, a dedicated webinar designed for industry leaders, emerging entrepreneurs, and professionals navigating today's talent landscape.
Speaking Engagements

7.01.26

Wilson Sonsini and DLG to Co-Host Seminar on Building Long-Term Value in Korean Bio-ventures' Global Expansion
Wilson Sonsini is pleased to co-present this seminar alongside Korean law firm DLG, with attorneys Ian Edvalson, Minyoung Shin, and Ariel Jeong speaking on how Korean bio-ventures can build and sustain long-term enterprise value as they expand globally.
Affiliated Programs

6.24.26

Frontiers of Neuro
Wilson Sonsini is excited to sponsor an afternoon of networking and breakthrough presentations on the frontier of neuroscience, hosted by PsyMed Ventures and E11 Bio.
Affiliated Programs

6.18.26

Power of Single-Cell-Multi-Omics: From Bench to Bedside
Wilson Sonsini is pleased to support EPPIC Global.
Affiliated Programs

6.16.26

CBSA Thought Leadership Series: Intellectual Property
Wilson Sonsini is proud to sponsor the Colorado Bioscience Thought Leadership Series, a forum dedicated to exploring the critical strategic issues facing today’s life sciences companies.
Affiliated Programs

6.15.26

IPBC Global 2026
Wilson Sonsini is proud to sponsor the IPBC Global 2026 on June 15-17, 2026, at the InterContinental San Diego. Partner Michael Levin will serve as the moderator for this panel, "IP: The Voice of Value" on Wednesday, June 17 at 10:10 a.m.-11:10 a.m. and will be joined by leaders from Burford Capital, Qualcomm Technology Licensing, Dolby Laboratories, BASF and Sisvel International SA.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.